Identification of Potentially Undiagnosed Patients with Non-Tuberculous Mycobacterial Lung Disease Using Machine Learning Applied to Primary Care Data in UK

Nov-19

AUTHORS : Marko Obradovic, Senior Director, HEOR Europe, Insmed Germany GmbH, The Square 12, am Flughafen, Frankfurt (Frankfurt am Main), 60549, Germany – Email marko.obradovic@insmed.com

JOURNAL : Value in Health

REFERENCE: 22(S3):S879

DOI : 10.1016/j.jval.2019.09.2531

Identification of Potentially Undiagnosed Patients with Non-Tuberculous Mycobacterial Lung Disease Using Machine Learning Applied to Primary Care Data in UK

More publications

COPD Exacerbations Before and During COVID-19 in France, Germany, Italy, the UK and the US

Duration of Invasive Mechanical Ventilation before Veno-Venous ExtraCorporeal Membrane Oxygenation for Covid-19 related Acute Respiratory Distress Syndrome: The experience of a tertiary care center

Use and persistence of single and multiple inhaler triple therapy prescribed for patients with COPD in France: a retrospective study on THIN database (OPTI study)